You have access
Low-dose Pimecrolimus, an FDA-approved Calcineurin Inhibitor, Sensitizes Drug-resistant Cancer Cells via Strong P-gp Inhibition
JAE HYEON PARK, JI SUN LEE, JOO KYUNG SHIN, SWATI SHARMA, HYUNG SIK KIM and SUNGPIL YOON
Anticancer Research March 2023, 43 (3) 1103-1112; DOI: https://doi.org/10.21873/anticanres.16255